The presence of TERT mutation was associated with worse prognosis in breast cancer, thyroid carcinoma, and lung adenocarcinoma (37), meanwhile, TERT promoter mutations are highly associated with sarcomatoid histology in patients with metastatic pleural mesothelioma (38) and urothelial carcinomas (39). This evidence concerns the gene TERT and breast cancer.